According to the U.S. Patent Office, the claims are that it is:
1. A method of treating AIDS-afflicted humans comprising injecting a multitude of tetrasilver tetroxide molecular crystals into the bloodstream of the human subject.
2. A method for increasing white blood cell counts in AIDS-afflicted humans comprising injecting a multitude of tetrasilver tetroxide molecular crystals into the bloodstream of the human subject.
3. Methods of treating AIDS-affilicted humans according to claims 1-2 where the concentration of said molecular crystals is approximately 40 PPM of the total blood weight of the human subject.
This does not necessarily mean it is a cure.
To read more, visit the U.S. Patent site at the Related Link.
Highly unlikely if not impossible. For HIV transmission to occur you need blood to blood contact.
New York had and still have the highest rate of AIDS.
Yes it is documented to do so, just read the patent. The FDA won't ever approve anything that threatens pharmaceutical income... EVER!
About 1.1 people in the United States are infected with HIV/AIDS
1051875 or 38% of people are diagnosed with AIDS every year
Quantifying the number of viable bacteria in a sample is crucial for several reasons. It helps assess the effectiveness of antimicrobial treatments, monitor food safety, and evaluate environmental health. Additionally, understanding bacterial viability aids in research and development, ensuring proper dosing in clinical applications and enhancing our knowledge of microbial ecology. Accurate quantification ultimately supports better decision-making in healthcare, agriculture, and environmental management.
Africa
Miami
No; it is probably just a resource or help number only.
AIDS
Aids aids aids aids aids aids aids aids aids aids aids aids aids aids aids aids!!!!!!!!!!!!!!!!!!!!!!
stays the same